Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Glucuronidation of zileuton (A-64077) by human hepatic microsomes.

× No keyword cloud information.

6 in total

1. The effect of mild or moderate hepatic impairment (cirrhosis) on the pharmacokinetics of zileuton.

Authors: W M Awni; J H Cavanaugh; R A Braeckman; S Y Chu; K J Patterson; J M Machinist; G R Granneman
Journal: Clin Pharmacokinet Date: 1995 Impact factor: 6.447

2. Pharmacokinetics and pharmacodynamics of zileuton after oral administration of single and multiple dose regimens of zileuton 600mg in healthy volunteers.

Authors: W M Awni; R A Braeckman; G R Granneman; G Witt; L M Dubé
Journal: Clin Pharmacokinet Date: 1995 Impact factor: 6.447

3. Effect of zileuton on theophylline pharmacokinetics.

Authors: G R Granneman; R A Braeckman; C S Locke; J H Cavanaugh; L M Dubé; W M Awni
Journal: Clin Pharmacokinet Date: 1995 Impact factor: 6.447

4. The pharmacokinetics of single oral doses of zileuton 200 to 800mg, its enantiomers, and its metabolites, in normal healthy volunteers.

Authors: S L Wong; W M Awni; J H Cavanaugh; T el-Shourbagy; C S Locke; L M Dubé
Journal: Clin Pharmacokinet Date: 1995 Impact factor: 6.447

5. The properties of A-69412: a small hydrophilic 5-lipoxygenase inhibitor.

Authors: R L Bell; J Bouska; P R Young; C Lanni; J Machinist; P E Malo; J B Summers; D W Brooks; G W Carter
Journal: Agents Actions Date: 1993-03

6. Population pharmacokinetics of zileution, a selective 5-lipoxygenase inhibitor, in patients with rheumatoid arthritis.

Authors: W M Awni; G R Granneman; C S Locke; S R Brandwein; L M Dube
Journal: Eur J Clin Pharmacol Date: 1995 Impact factor: 2.953

6 in total